Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sonoma Pharmaceuticals (SNOA) Asset Utilization Ratio (2016 - 2025)

Sonoma Pharmaceuticals has reported Asset Utilization Ratio over the past 15 years, most recently at 1.29 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 26.25% year-over-year to 1.29; the TTM value through Dec 2025 reached 1.29, up 26.25%, while the annual FY2025 figure was 1.01, 22.21% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 1.29 at Sonoma Pharmaceuticals, up from 1.19 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.29 in Q4 2025 and troughed at 0.64 in Q4 2021.
  • A 5-year average of 0.92 and a median of 0.88 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 44.21% in 2021 and later skyrocketed 36.35% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.64 in 2021, then soared by 36.35% to 0.87 in 2022, then grew by 0.25% to 0.87 in 2023, then grew by 17.24% to 1.02 in 2024, then rose by 26.25% to 1.29 in 2025.
  • Business Quant data shows Asset Utilization Ratio for SNOA at 1.29 in Q4 2025, 1.19 in Q3 2025, and 1.05 in Q2 2025.